pramipexole dihydrochloride 1.5 mg
1 INDICATIONS AND USAGE Pramipexole dihydrochloride extended- release tablet is a non-ergot dopamine agonist indicated for the treatment of Parkinson's disease (PD) ( 1 ) Pramipexole dihydrochloride extended- release tablets are indicated for the treatment of Parkinson's disease.
ingenus pharmaceuticals, llc
OVAL WHITE P13 1 5
Related Pills
pramipexole dihydrochloride 4.5 mg
ingenus pharmaceuticals, llc
pramipexole dihydrochloride 3.75 mg
ingenus pharmaceuticals, llc
pramipexole dihydrochloride 3 mg
ingenus pharmaceuticals, llc
pramipexole dihydrochloride 2.25 mg
ingenus pharmaceuticals, llc
pramipexole dihydrochloride 0.75 mg
ingenus pharmaceuticals, llc
pramipexole dihydrochloride 0.375 mg
ingenus pharmaceuticals, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
PRAMIPEXOLE DIHYDROCHLORIDE extended- release tablets are available as follows: 0.375 mg: white or off-white, round, biconvex tablets debossed "0.375" on one side and "P11" on the other side. Unit of Use Bottles of 30 NDC 50742-331-30 0.75 mg: white or off-white, round, biconvex tablets debossed "0.75" on one side and "P12" on the other side. Unit of Use Bottles of 30 NDC 50742-332-30 1.5 mg: white or off-white, oval, biconvex tablets debossed "1.5" on one side and "P13" on the other side. Unit of Use Bottles of 30 NDC 50742-333-30 2.25 mg: white or off-white, oval, biconvex tablets debossed "2.25" on one side and "P14" on the other side. Unit of Use Bottles of 30 NDC 50742-334-30 3 mg: white or off-white, oval, biconvex tablets debossed "3.0" on one side and "P15" on the other side. Unit of Use Bottles of 30 NDC 50742-335-30 3.75 mg: white or off-white, oval, biconvex tablets debossed "3.75" on one side and "P16" on the other side. Unit of Use Bottles of 30 NDC 50742-336-30 4.5 mg: white or off-white, oval, biconvex tablets debossed "4.5" on one side and "P17" on the other side. Unit of Use Bottles of 30 NDC 50742-337-30 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from exposure to high humidity. Store in a safe place out of the reach of children.
More pills like OVAL P13 1 5